Neoadjuvant Pazopanib in Renal Cell Carcinoma

Study ID Alternative Stable ID Type
phs002053 Prospective

Study Description

This study examined the tissue of patients who received oral pazopanib prior to nephrectomy. Patients were consented and underwent a pre-treatment biopsy. Pretreatment samples for analysis were preserved as available. Subjects underwent a proscribed course of treatment with pazopanib. At the completion of treatment, subjects underwent a planned nephrectomy, and samples were collected from the nephrectomy specimen. We recorded response to treatment, adverse events, and 2 year follow up for recurrence.

Archive Link Archive Accession
dbGaP phs002053

Who archives the data?

There are no publications available